Table 1.
Summary of inhibitors and reversal/bypass agents
Inhibitor | Target | Reversal/bypass agents |
---|---|---|
3sQ-SNAREs | R-SNARE | Secl8p, PI(4,5)P2 |
αSecl8p | Secl8p | Secl8p, Vam7p |
αVam3p | Vam3p | None known |
αVps33p | Vps33p | None known |
αYpt7 | Ypt7p | Ypt7p effector peptide |
250 mM KC1 | Unknown | Lowered salt |
U73122 | Phospholipase C | Vam7p |
ENTH domain | PI(4,5)P2 | Chlorpromazine (CPZ) |
PX domain | PI(3)P | Vam7p, CPZ |
Clb domain | Diacylglycerol | Vam7p, CPZ |
MED peptide | PIPx | CPZ, PI(4,5)P2 |